H.C. Wainwright Reiterates Buy Rating on Akari Therapeutics (AKTX)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall St set for higher open as Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
| (NASDAQ: AKTX) | Delayed: 8.15 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $8.15 | 52 Week High | $19.75 | |||
| Open | $8.15 | 52 Week Low | $7.63 | |||
| Day High | $8.15 | P/E | N/A | |||
| Day Low | $8.15 | EPS | $0.00 | |||
| Volume | 235 | |||||
